Pro-Dex (PDEX) to Release Earnings on Thursday

Pro-Dex (NASDAQ:PDEX) is expected to release its Q3 2025 earnings data before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of $0.47 per share and revenue of $17.70 million for the quarter.

Pro-Dex (NASDAQ:PDEX) last announced its quarterly earnings data on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. On average, analysts expect Pro-Dex to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Pro-Dex Stock Performance

NASDAQ:PDEX opened at $69.00 on Tuesday. The company has a market cap of $225.01 million, a P/E ratio of 34.33 and a beta of 0.40. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.33. Pro-Dex has a twelve month low of $16.84 and a twelve month high of $70.26. The company’s 50-day moving average price is $49.90 and its 200-day moving average price is $44.94.

Insider Buying and Selling at Pro-Dex

In other news, Director Raymond E. Cabillot sold 842 shares of the company’s stock in a transaction that occurred on Friday, March 28th. The shares were sold at an average price of $50.00, for a total value of $42,100.00. Following the transaction, the director now directly owns 278,945 shares in the company, valued at approximately $13,947,250. This represents a 0.30 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders have sold 22,483 shares of company stock worth $1,080,693 over the last quarter. 47.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered Pro-Dex from a “buy” rating to a “hold” rating in a research note on Wednesday, March 12th.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.